From our humble beginnings two years ago, in March 2012 we consented our 400th patient to the APGI. This is a significant milestone and positions us very close to achieving our overall goal of 500 patients. Click here for our most recent research update.
We've recruited 308 patients to date, generating 1531 tumour samples. Genomic sequence analysis and mutation verification have been completed on 70 pancreatic tumour/normal exome datasets. Read our December 2011 issue for exciting updates on project milestones this Christmas.
In our inaugural issue, we highlight the aims and purpose of the APGI from the clinical perspective, with a spotlight on Fremantle Hospital, WA, one of our earliest inter-state collaborators to come on-board.